The physiologic and phenotypic alterations due to macrolide exposure in Campylobacter jejuni

International Journal of Food Microbiology

Volumn 151, Issue 1, 2011, Pages 52-61

  Almofti, Yassir A ^a   Dai, Menghong ^a   Sun, Yawei ^a   Hao, Haihong ^a   Liu, Zhenli ^a   Cheng, Guyue ^a   Yuan, Zonghui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

C. jejuni; Fitness; Flagellin; Macrolides; Motility

Indexed keywords

AGAR; FLAGELLIN; MACROLIDE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; CAMPYLOBACTER JEJUNI; ELECTRON MICROSCOPY; FLAGELLUM; IMMUNOBLOTTING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SYNTHESIS;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER JEJUNI; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLAGELLA; FLAGELLIN; GENETIC FITNESS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOTYPE;

CAMPYLOBACTER JEJUNI;

EID: 80053452156     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2011.08.002     Document Type: Article

References (50)

1. Allos B.M. Campylobacter jejuni infections: update on emerging issues and trends. Clinical Infectious Diseases 2001, 32(8):1201-1206.
2. Almofti Y.A., Dai M., Sun Y., Haihong H., Yuan Z. Impact of erythromycin resistance on the virulence properties and fitness of Campylobacter jejuni. Microbial Pathogenesis 2011, 10.1016/j.micpath.2011.02.009.
3. Anderson R., Steel H.C., Cockeran R., von Gottberg A., de Gouveia L., Klugman K.P., Mitchell T.J., Feldman C. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. Journal of Antimicrobial Chemotherapy 2007, 10.1093/jac/dkm338.
4. Andersson D.I. The biological cost of mutational antibiotic resistance: any practical conclusions?. Current Opinion in Microbiology 2006, 9:461-465.
5. Berg H.C. The rotary motor of bacterial flagella. Annual Review of Biochemistry 2003, 72:19-54.
6. Black R.E., Levine M.M., Clements M.L., Hughes T.P., Blaser M.J. Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases 1988, 157:472-479.
7. Butzler J.P. Campylobacter, from obscurity to celebrity. Journal of Clinical Microbiology 2004, 10:868-876.
8. Cagliero C., Mouline C., Cloeckaert A., Payot S. Synergy between efflux pump Cme-ABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrobial Agents and Chemotherapy 2006, 50:3893-3896.
9. Caldwell D.B., Wang Y., Lin J. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2008, 52:3947-3954.
10. Clinical, Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Approved Standard 2008, CLSI, Wayne, PA, document M31-A3. Third edition.
11. Corcoran D., Quinn T., Cotter L., Fanning S. An investigation of the molecular mechanisms contributing to high-level resistance in Campylobacter. International Journal of Antimicrobial Agents 2006, 27:40-45.
12. Engberg J., Aarestrup F.M., Taylor D.E., Gerner-Smidt P., Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerging Infectious Diseases 2001, 7:24-34.
13. Enne V.I., Delsol A.A., Roe J.M., Bennett P.M. Rifampicin resistance and its fitness cost in Enterococcus faecium. Journal of Antimicrobial Chemotherapy 2004, 53:203-207.
14. Ferrero R.L., Lee A. Motility of Campylobacter jejuni in a viscous environment: comparison with conventional rod-shaped bacteria. Journal of General Microbiology 1988, 134:53-59.
15. Gibreel A., Kos V.N., Keelan M., Trieber C.A., Levesque S., Michaud S., Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrobial Agents and Chemotherapy 2005, 49:2753-2759.
16. Guerry P. Campylobacter flagella: not just for motility. Trends in Microbiology 2007, 15(10):456-461.
17. Guerry P., Alm R.A., Power M.E., Logan S.M., Trust T.J. Role of two flagellin genes in Campylobacter motility. Journal of Bacteriology 1991, 173:4757-4764.
18. Han F., Pu S., Wang F., Meng J., Ge B. Fitness cost of macrolide resistance in Campylobacter jejuni. International Journal of Antimicrobial Agents 2009, 34(5):462-466.
19. Hao H., Dai M., Wang Y., Peng D., Liu Z., Yuan Z. 23S rRNA mutation A2074C conferring high-level macrolide resistance and fitness cost in Campylobacter jejuni. Microbial Drug Resistance 2009, 15(4):239-244. 10.1089/mdr.2009.0008.
20. Jensen L.B., Aarestrup F.M. Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrobial Agents and Chemotherapy 2001, 45:371-372.
21. Joshua G.W.P., Guthrie-Irons C., Karlyshev A.V., Wren B.W. Biofilm formation in Campylobacter jejuni. Journal of Microbiology 2006, 152:387-396.
22. Kalmokoff M., Lanthier P., Tremblay T., Foss M., Lau P.C., Sanders G., Austin J., Kelly J., Szymanski C.M. Proteomic analysis of Campylobacter jejuni 11168 biofilms reveals a role for the motility complex in biofilm formation. Journal of Bacteriology 2006, 188:4312-4320.
23. Kawamura-Sato K., Iinuma Y., Hasegawa T., Horii T., Yamashino T., Ohta M. Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. Antimicrobial Agents and Chemotherapy 2000, 44:2869-2872.
24. Komoriya K., Shibano N., Higano T., Azuma N., Yamaguchi S., Aizawa S.I. Flagellar proteins and type III-exported virulence factors are the predominant proteins secreted into the culture media of Salmonella typhimurium. Molecular Microbiology 1999, 34:767-779.
25. Konkel M.E., Klena J.D., Rivera-Amill V., Monteville M.R., Biswas D., Raphael B., Mickelson J. Secretion of virulence proteins from Campylobacter jejuni is dependent on a functional flagellar export apparatus. Journal of Bacteriology 2004, 186:3296-3303.
26. Lin J., Michel L.O., Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2002, 46:2124-2131.
27. Lin J., Yan M., Sahin O., Pereira S., Chang Y.J., Zhang Q. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrobial Agents and Chemotherapy 2007, 51:1678-1686.
28. Linares J.F., Lopez J.A., Camafeita E., Albar J.P., Rojo F., Martinez J.L. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. Journal of Bacteriology 2005, 187:1384-1391.
29. Martinez J.L., Baquero F. Mutation frequencies and antibiotic resistance. Antimicrobial Agents and Chemotherapy 2000, 44:1771-1777.
30. Martinez J.L., Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clinical Microbiology Reviews 2002, 15(4):647-679.
31. Matsui H., Eguchi M., Ohsumi K., Nakamura A., Isshiki Y., Sekiya K., Kikuchi Y., Nagamitsu T., Masuma R., Sunazuka T., Omura S. Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica Serovar Typhimurium. Antimicrobial Agents and Chemotherapy 2005, 49:3396-3403.
32. Misawa N., Blaser M.J. Detection and characterization of autoagglutination activity by Campylobacter jejuni. Infection and Immunity 2000, 68:6168-6175.
33. Molinari G., Paglia P., Schito G.C. Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. European Journal of Clinical Microbiology and Infectious Diseases 1992, 11:469-471.
34. Molonari G., Guzman C.A., Pesce A., Schito G.C. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. Journal of Antimicrobial Chemotherapy 1993, 31:681-688.
35. Nachamkin I., Yang X.H., Stern N.J. Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis with flagellar mutants. Applied and Environmetal Microbiology 1993, 59:1269-1273.
36. Nilsson A.I., Zorzet A., Kanth A., Dahlstrom S., Berg O.G., Andersson D.I. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6976-6981.
37. Nobata K., Ina K., Ohta M., Kawamura-Sato K., Tsuzuki T., Ando T., Kusugami K. Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates. Digestive and Liver Disease 2002, 34(7):489-497.
38. Nuijten P.J., van Asten F.J., Gaastra W., van der Zeijst B.A. Structural and functional analysis of two Campylobacter jejuni flagellin genes. Journal of Biological Chemistry 1990, 265:17798-17804.
39. O'Neill A.J., Huovinen T., Fishwick C.W., Chopra I. Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampicin resistance genotypes in relation to clinical prevalence. Antimicrobial Agents and Chemotherapy 2006, 50:298-309.
40. Payot S., Cloeckaert A., Chaslus-Dancla E. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microbial Drug Resistance 2002, 8:335-343.
41. Poly F., Ewing C., Goon S., Hickey T.E., Rockabrand D., Majam G., Lanfong L., Phan J., Savarino N.J., Guerry P. Heterogeneity of a Campylobacter jejuni protein that is secreted through the flagellar filament. Infection and Immunity 2007, 75:3859-3867.
42. Pumbwe L., Piddock L.J. Identification and molecular characterization of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiology Letters 2002, 206:185-189.
43. Riddle M.S., Sanders J.W., Putnam S.D., Tribble D.R. Incidence, etiology and impact of diarrhea among long-term travelers (US military and similar populations): a systemic review. The American Journal of Tropical Medicine and Hygiene 2006, 74:891-900.
44. Shryock T.R., Mortensen J.E., Baumholtz M. The effects of macrolides on the expression of bacterial virulence mechanisms. Journal of Antimicrobial Chemotherapy 1998, 41(5):505-512.
45. Skirrow M.B., Blaser M.J. Clinical aspects of Campylobacter infection. Campylobacter 2000, ASM Press, Washington, D.C. 2nd ed. I. Nachamkin, M.J. Blaser (Eds.).
46. Song Y.C., Jin S., Louie H., Ng D., Lau R., Zhang Y., Weerasekera R., Al Rashid S., Ward L.A., Der S.D., Chan V.L. FlaC, a protein of Campylobacter jejuni TGH9011 (ATCC43431) secreted through the flagellar apparatus, binds epithelial cells and influences cell invasion. Molecular Microbiology 2004, 53:541-553.
47. Szymanski C.M., Malcolm K., Haardt M., Armstrong G.D. Campylobacter jejuni motility and invasion of Caco-2 cells. Infection and Immunity 1995, 63:4295-4300.
48. Wang Y., Taylor D.E. Natural transformation in Campylobacter species. Journal of Bacteriology 1990, 172:949-955.
49. Wassenaar T.M., van der Zeijst B.A., Ayling R., Newell D.G. Colonization of chicks by motility mutants of Campylobacter jejuni demonstrates the importance of flagellin A expression. Journal of General Microbiology 1993, 139:1171-1175.
50. Zaman S., Fitzpatrick M., Lindahl L., Zengel J. Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli. Molecular Microbiology 2007, 66(4):1039-1050.